시장보고서

상품코드

1553515

부정맥 모니터링 디바이스 시장 규모, 점유율, 동향 분석 리포트 : 제품별, 용도별, 최종 용도별, 지역별, 부문별 예측(2024-2030년)

Arrhythmia Monitoring Devices Market Size, Share & Trends Analysis Report By Product (ECG, Implantable Cardiac Monitors, Holter Monitors, Mobile Cardiac Telemetry), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 200 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

부정맥 모니터링 디바이스 시장의 성장과 동향 :

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 부정맥 모니터링 디바이스 시장 규모는 예측 기간 중 CAGR 7.2%로 2030년에 116억 3,000만 달러에 달할 전망입니다.

심장 모니터링 분야의 지속적인 연구개발 활동은 기술적 확장을 가져오고 있습니다. iRhythm Technologies, Inc.의 Zio의 웨어러블 진단 패치는 기존의 홀터 모니터에 비해 우수한 대증요법적 부정맥 모니터링 기능을 제공함으로써 부정맥 모니터링 디바이스 시장의 성장에 긍정적인 영향을 미치고 있습니다.

대형 제약회사와 의료기기 회사들은 심장 부정맥의 상세한 매핑을 위한 연구개발에 많은 투자를 하고 있으며, 2018년 2월, 메드트로닉은 최초의 비침습적 심장 매핑 시스템인 CardioInsight의 FDA 승인을 획득했습니다. 이 시스템에는 웨어러블 252 전극 센서 조끼가 포함되어 있으며, 심장 컴퓨터 단층촬영 스캔 데이터와 흉부 부위에서 수집한 ECG 신호를 결합하여 심장의 3D 전기 해부학적 지도를 생성합니다.

이러한 기술 외에도 모바일 심장 원격 측정의 출현과 발전은 전체 시장을 더욱 발전시키고 있으며, 2017년 10월 Abbott는 부정맥 진단에 적응하는 스마트폰 지원 이식형 심장 모니터 Confirm Rx의 FDA 승인을 획득했습니다. 보스턴 사이언티픽(Boston Scientific)은 심장 관리를 위한 심장 재동기화 치료 제세동기 및 제세동기 시스템 라인업인 Resonate에 대한 FDA 승인을 발표했습니다.

부정맥 모니터링 디바이스 시장 보고서의 주요 내용 :

2023년 매출액 기준 홀터 모니터가 시장을 장악할 것으로 예상됩니다. 반면, 모바일 심장 원격 측정은 예측 기간 중 가장 빠른 성장률을 보일 것으로 예상됩니다.
심방세동은 2023년 매출으로 시장을 장악했습니다. 치료되지 않은 부정맥의 수가 증가함에 따라 고급 심장 모니터링 장비에 대한 수요가 증가하고 있습니다.
정교한 기술 채택이 진행되면서 시장이 확대되고 있으며, AliveCor의 Kardia Mobile은 30초 만에 심전도를 촬영해 심방세동과 같은 심장 리듬을 포착합니다.
2023년 시장에서는 병원 및 클리닉 부문이 가장 큰 점유율을 차지했습니다. 반면, 진단센터는 예측 기간 중 가장 빠르게 성장할 가능성이 높습니다.

부정맥 모니터링 디바이스 시장 : 제품별 대시보드
부정맥 모니터링 디바이스 시장 : 제품별 변동 분석
부정맥 모니터링 디바이스 시장 규모와 예측 및 동향 분석, 제품별, 2018-2030년
심전도
이식형 심장 모니터
홀터 모니터
모바일 심장 텔레메트리

제5장 부정맥 모니터링 디바이스 시장 : 용도별 추정·동향 분석

부정맥 모니터링 디바이스 시장 : 용도별 대시보드
부정맥 모니터링 디바이스 시장 : 용도별 변동 분석
부정맥 모니터링 디바이스 시장 규모와 예측 및 동향 분석, 용도별, 2018-2030년
서맥
- 2018-2030년 시장 추산·예측
빈맥
- 2018-2030년 시장 추산·예측
심방세동
- 2018-2030년 시장 추산·예측
심실세동
- 2018-2030년 시장 추산·예측
조기 수축
- 2018-2030년 시장 추산·예측
기타
- 2018-2030년 시장 추산·예측

제6장 부정맥 모니터링 디바이스 시장 : 최종 용도별 추정·동향 분석

부정맥 모니터링 디바이스 시장 : 최종 용도별 대시보드
부정맥 모니터링 디바이스 시장 : 최종 용도별 변동 분석
부정맥 모니터링 디바이스 시장 규모와 예측 및 동향 분석, 최종 용도별, 2018-2030년
병원
진단 센터
기타

제7장 부정맥 모니터링 디바이스 시장 : 국가, 제품, 용도, 최종 용도별 지역 추정·동향 분석

세계의 부정맥 모니터링 디바이스 시장 : 지역별 대시보드
시장 규모와 예측 동향 분석, 2018-2030년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카

제8장 경쟁 구도

주요 제조업체에 의한 최근 동향과 영향 분석
기업/경쟁의 분류
벤더 구도
- 주요 판매 대리점 및 채널 파트너 리스트
- 주요 고객
- 주요 기업의 시장 점유율 분석, 2023년
- Abbott Laboratories
- GE HealthCare
- iRhythm Technologies, Inc.
- Medtronic
- Koninklijke Philips NV
- Spacelabs Healthcare(OSI Systems, Inc.)
- Fukuda Denshi Co., Ltd.
- Boston Scientific Corporation
- Nihon Kohden Corporation
- Baxter
- Zoll Medical Corporation(Asahi Kasei Corporation)
- Biotronik

KSA 24.09.25

Arrhythmia Monitoring Devices Market Growth & Trends:

The global arrhythmia monitoring devices market size is expected to reach USD 11.63 billion in 2030 with a CAGR of 7.2% during the forecast period, according to a new report by Grand View Research, Inc. Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.

Big pharma and medical device companies are heavily investing in R&D to perform a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for the first non-invasive cardiac mapping system, CardioInsight. It includes wearable 252-electrode sensor vest that creates 3D electroanatomic maps of heart by combining data from a cardiac computed tomography scan with ECG signals collected from the chest region.

In addition to these technologies, emergence and advancements in mobile cardiac telemetry are leading to further progress of the overall market. In October 2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible implantable cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced its FDA approval for Resonate, a line of cardiac resynchronization therapy defibrillator and cardioverter defibrillator systems for the cardiac management.

Arrhythmia Monitoring Devices Market Report Highlights:

Holter monitors dominated the market in terms of revenue in 2023. On the other hand, mobile cardiac telemetry is expected to witness the fastest growth rate during the forecast period
Atrial fibrillation dominated the market in terms of revenue in 2023. The growth in the number of untreated cases of arrhythmias are leading to increasing need for advanced cardiac monitoring devices
Heightened adoption of sophisticated technologies has led to the expansion of the market. Kardia Mobile by AliveCor captures ECG in 30 seconds projecting the heart rhythm for conditions such as atrial fibrillation
The hospitals and clinics segment held the largest share in the market in 2023. On the other hand, diagnostic centers are likely to experience the fastest growth over the forecast period

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.2.4. Regional scope
- 1.2.5. Estimates and forecast timeline.
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity price analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Product Segment
- 2.2.2. Application Segment
- 2.2.3. End Use Segment
- 2.2.4. Regional Outlook
2.3. Competitive Insights

Chapter 3. Global Arrhythmia Monitoring Devices Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Growing prevalence of arrhythmia
  - 3.2.1.2. Increasing awareness and screening programs
  - 3.2.1.3. Technological advancements in monitoring devices
- 3.2.2. Market restraint analysis
  - 3.2.2.1. High cost associated with the devices and procedures
  - 3.2.2.2. Regulatory compliance
3.3. Arrhythmia Monitoring Devices Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's Five Forces
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Arrhythmia Monitoring Devices Market: Product Estimates & Trend Analysis

4.1. Arrhythmia Monitoring Devices Market: Product Dashboard
4.2. Arrhythmia Monitoring Devices Market: Product Movement Analysis
4.3. Arrhythmia Monitoring Devices Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
4.4. ECG
- 4.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.5. Implantable Cardiac Monitors
- 4.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.6. Holter Monitors
- 4.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
4.7. Mobile Cardiac Telemetry
- 4.7.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Arrhythmia Monitoring Devices Market: Application Estimates & Trend Analysis

5.1. Arrhythmia Monitoring Devices Market: Application Dashboard
5.2. Arrhythmia Monitoring Devices Market: Application Movement Analysis
5.3. Arrhythmia Monitoring Devices Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
5.4. Bradycardia
- 5.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.5. Tachycardia
- 5.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.6. Atrial Fibrillation
- 5.6.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.7. Ventricular Fibrillation
- 5.7.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.8. Premature Contraction
- 5.8.1. Market estimates and forecast 2018 to 2030 (USD Million)
5.9. Others
- 5.9.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Arrhythmia Monitoring Devices Market: End Use Estimates & Trend Analysis

6.1. Arrhythmia Monitoring Devices Market: End Use Dashboard
6.2. Arrhythmia Monitoring Devices Market: End Use Movement Analysis
6.3. Arrhythmia Monitoring Devices Market Size & Forecasts and Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
- 6.4.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.5. Diagnostic Centers
- 6.5.1. Market estimates and forecast 2018 to 2030 (USD Million)
6.6. Others
- 6.6.1. Market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Arrhythmia Monitoring Devices Market: Regional Estimates & Trend Analysis by Country, Product, Application, & End Use

7.1. Global Arrhythmia Monitoring Devices Market: Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030
7.3. North America
- 7.3.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.3.2. U.S.
  - 7.3.2.1. Key country dynamics
  - 7.3.2.2. Regulatory framework/ reimbursement structure
  - 7.3.2.3. Competitive scenario
  - 7.3.2.4. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.3. Canada
  - 7.3.3.1. Key country dynamics
  - 7.3.3.2. Regulatory framework/ reimbursement structure
  - 7.3.3.3. Competitive scenario
  - 7.3.3.4. Canada market estimates and forecast, 2018 - 2030 (USD Million)
- 7.3.4. Mexico
  - 7.3.4.1. Key country dynamics
  - 7.3.4.2. Regulatory framework/ reimbursement structure
  - 7.3.4.3. Competitive scenario
  - 7.3.4.4. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
7.4. Europe
- 7.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.4.2. UK
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework/ reimbursement structure
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. UK market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.3. Germany
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework/ reimbursement structure
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. Germany market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.4. France
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework/ reimbursement structure
  - 7.4.4.3. Competitive scenario
  - 7.4.4.4. France market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.5. Italy
  - 7.4.5.1. Key country dynamics
  - 7.4.5.2. Regulatory framework/ reimbursement structure
  - 7.4.5.3. Competitive scenario
  - 7.4.5.4. Italy market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.6. Spain
  - 7.4.6.1. Key country dynamics
  - 7.4.6.2. Regulatory framework/ reimbursement structure
  - 7.4.6.3. Competitive scenario
  - 7.4.6.4. Spain market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.7. Sweden
  - 7.4.7.1. Key country dynamics
  - 7.4.7.2. Regulatory framework/ reimbursement structure
  - 7.4.7.3. Competitive scenario
  - 7.4.7.4. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.8. Norway
  - 7.4.8.1. Key country dynamics
  - 7.4.8.2. Regulatory framework/ reimbursement structure
  - 7.4.8.3. Competitive scenario
  - 7.4.8.4. Norway market estimates and forecast, 2018 - 2030 (USD Million)
- 7.4.9. Denmark
  - 7.4.9.1. Key country dynamics
  - 7.4.9.2. Regulatory framework/ reimbursement structure
  - 7.4.9.3. Competitive scenario
  - 7.4.9.4. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
7.5. Asia Pacific
- 7.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. China market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.3. Japan
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. Japan market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.4. India
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/ reimbursement structure
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. India market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.5. Australia
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework/ reimbursement structure
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. Australia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework/ reimbursement structure
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
- 7.5.7. South Korea
  - 7.5.7.1. Key country dynamics
  - 7.5.7.2. Regulatory framework/ reimbursement structure
  - 7.5.7.3. Competitive scenario
  - 7.5.7.4. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
7.6. Latin America
- 7.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.6.2. Brazil
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
- 7.6.3. Argentina
  - 7.6.3.1. Key country dynamics
  - 7.6.3.2. Regulatory framework/ reimbursement structure
  - 7.6.3.3. Competitive scenario
  - 7.6.3.4. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
7.7. MEA
- 7.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.3. South Africa
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/ reimbursement structure
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.4. UAE
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/ reimbursement structure
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. UAE market estimates and forecast, 2018 - 2030 (USD Million)
- 7.7.5. Kuwait
  - 7.7.5.1. Key country dynamics
  - 7.7.5.2. Regulatory framework/ reimbursement structure
  - 7.7.5.3. Competitive scenario
  - 7.7.5.4. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis, By Key Manufacturers
8.2. Company/Competition Categorization
8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2023
- 8.3.4. Abbott Laboratories
  - 8.3.4.1. Company overview
  - 8.3.4.2. Financial performance
  - 8.3.4.3. Product benchmarking
  - 8.3.4.4. Strategic initiatives
- 8.3.5. GE HealthCare
  - 8.3.5.1. Company overview
  - 8.3.5.2. Financial performance
  - 8.3.5.3. Product benchmarking
  - 8.3.5.4. Strategic initiatives
- 8.3.6. iRhythm Technologies, Inc.
  - 8.3.6.1. Company overview
  - 8.3.6.2. Financial performance
  - 8.3.6.3. Product benchmarking
  - 8.3.6.4. Strategic initiatives
- 8.3.7. Medtronic
  - 8.3.7.1. Company overview
  - 8.3.7.2. Financial performance
  - 8.3.7.3. Product benchmarking
  - 8.3.7.4. Strategic initiatives
- 8.3.8. Koninklijke Philips N.V.
  - 8.3.8.1. Company overview
  - 8.3.8.2. Financial performance
  - 8.3.8.3. Product benchmarking
  - 8.3.8.4. Strategic initiatives
- 8.3.9. Spacelabs Healthcare (OSI Systems, Inc.)
  - 8.3.9.1. Company overview
  - 8.3.9.2. Financial performance
  - 8.3.9.3. Product benchmarking
  - 8.3.9.4. Strategic initiatives
- 8.3.10. Fukuda Denshi Co., Ltd.
  - 8.3.10.1. Company overview
  - 8.3.10.2. Financial performance
  - 8.3.10.3. Product benchmarking
  - 8.3.10.4. Strategic initiatives
- 8.3.11. Boston Scientific Corporation
  - 8.3.11.1. Company overview
  - 8.3.11.2. Financial performance
  - 8.3.11.3. Product benchmarking
  - 8.3.11.4. Strategic initiatives
- 8.3.12. Nihon Kohden Corporation
  - 8.3.12.1. Company overview
  - 8.3.12.2. Financial performance
  - 8.3.12.3. Product benchmarking
  - 8.3.12.4. Strategic initiatives
- 8.3.13. Baxter
  - 8.3.13.1. Company overview
  - 8.3.13.2. Financial performance
  - 8.3.13.3. Product benchmarking
  - 8.3.13.4. Strategic initiatives
- 8.3.14. Zoll Medical Corporation (Asahi Kasei Corporation)
  - 8.3.14.1. Company overview
  - 8.3.14.2. Financial performance
  - 8.3.14.3. Product benchmarking
  - 8.3.14.4. Strategic initiatives
- 8.3.15. Biotronik
  - 8.3.15.1. Company overview
  - 8.3.15.2. Financial performance
  - 8.3.15.3. Product benchmarking
  - 8.3.15.4. Strategic initiatives